Holocene Advisors, LP Neurocrine Biosciences Inc Put Options Transaction History

Holocene Advisors, LP

  • $22.6 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $21 Million - $28.7 Million
-240,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $869,100 - $1.08 Million
10,000 Added 4.35%
240,000 $23 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $22.1 Million - $31.1 Million
230,000 New
230,000 $22.1 Million

Others Institutions Holding NBIX

# of Institutions
629
Shares Held
94.2M
Call Options Held
692K
Put Options Held
406K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email